Email Updates

You are here

2 SEPTEMBER 2022 VOLUME 24 ISSUE 35

Media Coverage

  • Proximity to male partners, having a mobile lifestyle and feelings about pregnancy and motherhood are some of the factors that influence continuity of PrEP use among South African women. The qualitative findings are from Dr Monique Wyatt of Harvard Global and Harvard Medical School and colleagues, who conducted a qualitative study identifying key influences of PrEP uptake and adherence among women intending to conceive.

    September 1, 2022
    aidsmap
  • In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in US history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.

    September 1, 2022
    General
    Science
  • For the very first time since its establishment by the World Health Organization (WHO) in 2016, the saliva self-testing strategy has been implemented in Cameroon as part of the project “HIV self-testing Africa Initiative”conducted for 22 months, between April 2020 and June 2022, by the Cameroonian Association for Social Marketing (Acms), thanks to a catalytic fund from Unitaid, a global health agency that works in the search for innovative solutions to prevent, diagnose and treat diseases faster, more efficiently and at lower cost in low- and middle-income countries.

    September 1, 2022
    General
    OI Canadian
  • In July, cancer research and treatment center City of Hope presented research at the 2022 International AIDS Conference that shed a positive spotlight on the continued push to better understand, treat, and combat HIV. The news reverberated around the world — the 66-year-old patient, who wishes to remain anonymous, is the oldest individual to achieve remission from both HIV and leukemia, following a successful stem cell transplant from a donor who possesses an extremely rare genetic mutation.

    September 1, 2022
    Healthline
  • Two biopharmaceutical companies will give $5 million and $500,000, respectively, to nonprofit organizations in the United States and abroad that are responding to the growing monkeypox outbreak. The pledges come as the early philanthropic response to the disease, which disproportionately affects LGBTQ people, has been fairly muted compared with the early days of COVID-19.

    September 1, 2022
    General
    Washington Post
  • The stunningly rapid development of COVID-19 vaccines has been one of the most spectacular examples of what science can deliver to humanity. The shots, while not perfect, have allowed us to return to relatively normal lives. Tweaked versions will continue to do so in the coming years. But imagine how many lives could have been saved if we had also had drugs that could have treated the coronavirus in those early, unnerving days of 2020, when vaccines were still in the lab and hospitals across the world were swamped with sick patients.

    August 31, 2022
    General
    The Telegraph
  • After initially fumbling its monkeypox response, the US government is making vaccines more widely available for people in gay men’s sexual networks, who remain the most affected by the disease. Yet a deeper uncertainty persists. We know the Jynneos vaccine produces an antibody response that can protect against smallpox and may provide similar protection against monkeypox. But precisely how effective this vaccine will be against this current outbreak of monkeypox remains unclear.

    August 31, 2022
    General
    Washington Post
  • US research agencies should make the results of federally funded research free to read as soon as they are published, the administration of President Joe Biden has announced. This is a momentous shift from current policies that permit a delay of up to a year before papers must be posted outside paywalls. Because the United States is the world’s biggest research funder, the change — to be implemented by the end of 2025, if not sooner — is a boost for the growing open access (OA) movement to make scientific research publicly available.

    August 30, 2022
    General
    Nature
  • Concern is growing that the scramble for scarce supplies of monkeypox vaccines could see some nations and high-risk groups miss out - recalling unequal global access to COVID-19 vaccines and HIV medication. The outbreak, which has reached nearly 100 countries outside of Africa, where the virus is endemic, is overwhelmingly being transmitted among men who have sex with men. They are getting priority for vaccination globally, but some face a longer wait than others.

    August 30, 2022
    General
    Thomson Reuters Foundation
  • Almost four months into the current outbreak, we now know that a substantial proportion of people with monkeypox are living with HIV. While people with well-controlled HIV and a high CD4 count do not appear to have more severe monkeypox illness, this might not be the case for those with more advanced HIV disease. What’s more, HIV-positive people may not respond as well to monkeypox vaccines, suggesting they should receive the most effective regimen possible.

    August 30, 2022
    General
    aidsmap
  • Australia has recorded the lowest number of HIV diagnoses since the start of the epidemic in the early 1980s. In 2021, there were just 552 new diagnoses of HIV in Australia, according to a new national report released by the University of New South Wales’ Kirby Institute. The report says the rate of new diagnoses has halved over the past 10 years, and that 98 percent of HIV-positive people on treatment had achieved viral suppression: meaning they couldn’t transmit the virus.

    August 30, 2022
    General
    Cosmos Magazine
  • Across the globe, one hundred and thirty-four countries are criminalized or prosecuted due to criminal laws against HIV transmission, non-disclosure and exposure. Lower rates of HIV treatment and viral suppression are present and more likely in those countries that criminalize the virus. In a recent article by Mandeep Dhaliwal, director of the HIV and Health Group for the United Nations Development Program, states that the decriminalization of HIV is “scientifically proven and morally correct.”

    August 30, 2022
    General
    HIV Plus Mag
  • Approximately 1.6 million people in the United States identify as transgender, and a disproportionate burden of HIV falls on these individuals, particularly in Black and Latinx communities. A recent CDC surveillance report noted that 92 percent of HIV-negative transgender women in the United States were aware of PrEP, but only 32 percent were using it or had used it in the past year.

    August 29, 2022
    TheBodyPro
  • Religious organisations have been identified as major agents of stigma and discrimination against persons living with HIV (PLHIV), as cases continue to rise in the country. At a day's capacity building workshop for selected journalists on "the law and media reportage on Sexual and Gender-based Violence (SGBV)" in Accra, discussants called for intensified education among religious leaders to promote effective management and preventive lifestyles against the disease.

    August 29, 2022
    General
    allAfrica
  • More than 1.06 million people were living with diagnosed HIV in the United States at the end of 2019, and almost 37,000 were newly diagnosed during the prior year, according to the latest Medical Monitoring Project (MMP) report from the Centers for Disease Control and Prevention. The report shows that people diagnosed with HIV face many challenges that contribute to racial/ethnic and other disparities in the US epidemic.

    August 29, 2022
    General
    POZ Magazine
  • People living with HIV appear to develop cardiovascular disease (CVD) and hypertension earlier than those without HIV, and they seem to be increasingly likely to develop chronic kidney disease (CKD), according to a new study. On average, CVD and hypertension occurred about 2 years earlier in people living with HIV. And from about age 40 on, CKD burden increased more quickly, the researchers report.

    August 29, 2022
    General
    Medscape
  • Healthcare systems around the world faced an unprecedented health crisis as the COVID-19 pandemic swept from country to country, leaving lives, livelihoods and economies in its wake. The intense focus on COVID-19 has resulted in other widespread diseases being relegated, with services and resources directed away from them. HIV is one such disease, where the infection rate among adolescent girls and young women in South Africa versus the rest of the population remains alarmingly high, with this demographic being disproportionately affected.

    August 28, 2022
    General
    Daily Maverick
  • Several networks of people living with HIV are pouring in support to the ongoing indefinite sit-in (since 21st July 2022) outside offices of India's AIDS programme, to demand an end of stockout of HIV medicines, and ensure minimum one-month dispensation of these medicines nationwide. The government of India's guidelines of 2018 state that those persons stable on the HIV therapy should get three-months' supply of these medicines. But ground reality is that people in several states are getting 3-10 days supply, or children getting medicines for adults or vice versa.

    August 27, 2022
    Modern Ghana
  • The latest HIV prevalence report in Kenya shows that as of 2018, some 91.7 percent of male Kenyans had undergone circumcision. The Ministry of Health made the revelations on Friday, August 26 during the launch of the latest HIV guidelines in Kenya. The Acting Director-General of Health Dr Patrick Amoth presided over the event at the Windsor Golf Hotel and Country Club in Nairobi.

    August 26, 2022
    The Standard
  • Academic journals will have to provide immediate access to papers that are publicly funded, providing a big win for advocates of open research and ending a policy that had allowed publishers to keep publications behind a paywall for a year, according to a White House directive announced on Thursday. In laying out the new policy, which is set to be fully in place by the start of 2026, the Office of Science and Technology Policy said that the guidance had the potential to save lives and benefit the public on several key priorities — from cancer breakthroughs to clean-energy technology.

    August 25, 2022
    General
    The New York Times

Published Research

Announcements